Affiliation:
1. Graduate Institute of Biomedical Materials and Tissue Engineering College of Biomedical Engineering Taipei Medical University New Taipei City 235603 Taiwan
2. Department of Urology School of Medicine College of Medicine Taipei Medical University 250 Wu‐Hsing Street Taipei 11031 Taiwan
3. Taipei Medical University Research Center of Urology and Kidney Taipei Medical University 250 Wu‐Hsing Street Taipei 11031 Taiwan
4. Department of Urology Shuang Ho Hospital Taipei Medical University 291 Zhongzheng Road, Zhonghe District New Taipei City 23561 Taiwan
5. Department of Orthopedics and Trauma Faculty of Medicine University of Medicine and Pharmacy Ho Chi Minh City 700000 Vietnam
6. International Ph.D. Program in Biomedical Engineering College of Biomedical Engineering Taipei Medical University New Taipei City 235603 Taiwan
7. Cell Physiology and Molecular Image Research Center Taipei Medical University‐Wan Fang Hospital Taipei 11696 Taiwan
8. Precision Medicine and Translational Cancer Research Center Taipei Medical University Hospital Taipei 11031 Taiwan
Abstract
AbstractThrombosis presents a critical health threat globally, with high mortality and incidence rates. Clinical treatment faces challenges such as low thrombolytic agent bioavailability, thrombosis recurrence, ischemic hypoxia damage, and neural degeneration. This study developed biocompatible Chlamydomonas Reinhardtii micromotors (CHL) with photo/magnetic capabilities to address these needs. These CHL micromotors, equipped with phototaxis and photosynthesis abilities, offer promising solutions. A core aspect of this innovation involves incorporating polysaccharides (glycol chitosan (GCS) and fucoidan (F)) into ferric Metal‐organic frameworks (MOFs), loaded with urokinase (UK), and subsequently self‐assembled onto the multimodal CHL, forming a core‐shell microstructure (CHL@GCS/F‐UK‐MOF). Under light‐navigation, CHL@GCS/F‐UK‐MOF is shown to penetrate thrombi, enhancing thrombolytic biodistribution. Combining CHL@GCS/F‐UK‐MOF with the magnetic hyperthermia technique achieves stimuli‐responsive multiple‐release, accelerating thrombolysis and rapidly restoring blocked blood vessels. Moreover, this approach attenuates thrombi‐induced ischemic hypoxia disorder and tissue damage. The photosynthetic and magnetotherapeutic properties of CHL@GCS/F‐UK‐MOF, along with their protective effects, including reduced apoptosis, enhanced behavioral function, induced Heat Shock Protein (HSP), polarized M2 macrophages, and mitigated hypoxia, are confirmed through biochemical, microscopic, and behavioral assessments. This multifunctional biomimetic platform, integrating photo‐magnetic techniques, offers a comprehensive approach to cardiovascular management, advancing related technologies.
Funder
National Science and Technology Council